المؤلفون: Tanya Kadiyska, Radostina Cherneva, Zheina Cherneva, Sotir Marchev, Dilyana Madzharova, Ivan Tourtourikov, Vanyo Mitev

المصدر: Pharmacia, Vol 71, Iss , Pp 1-8 (2024)

مصطلحات موضوعية: Pharmacy and materia medica, RS1-441

وصف الملف: electronic resource

العلاقة: https://pharmacia.pensoft.net/article/120638/download/pdfTest/; https://pharmacia.pensoft.net/article/120638/download/xmlTest/; https://pharmacia.pensoft.net/article/120638Test/; https://doaj.org/toc/2603-557XTest

الوصول الحر: https://doaj.org/article/d8ac733d1cca4b9192a49bc622ca6ed3Test

المؤلفون: John Alexander, Jose Nicolau, Olga Godlevska, Valentyn Maslovskyi, Piotr Feusette, Tamina Levy, António Gaspar, Robert Storey, Julio Núñez, Maria Christiane Valeria Braga Braile-Sternieri, Sotir Marchev, Yury Shvarts, Sakac, Joerg Strobel, Diana Gorog, Elena Kosmacheva, Daniel Scherr, Peter Sinnaeve, Lars Maier, WILLIAM HEDDLE, Grishaev S.L., Oleg Averkov, Jan Fedacko, Daniel Pella, Ivo Petrov, Sergei Shalaev, Amos Katz, Meyer ELBAZ, Ziad Hijazi, Viktor Tashchuk, Svetlana Boldueva, Francesco Costa, Fausto J. Pinto, Jerzy Wranicz, Adrian Wlodarczak, David Brieger, Peter Nordbeck, Rodrigo Bagur, Andrzej Budaj

المساهمون: UCL - SSS/IREC/MONT - Pôle Mont Godinne, UCL - SSS/IREC/CARD - Pôle de recherche cardiovasculaire, UCL - (MGD) Service de cardiologie

المصدر: The New England journal of medicine, Vol. 380, no. 16, p. 1509-1524 (2019)

مصطلحات موضوعية: Male, medicine.medical_specialty, Acute coronary syndrome, Vitamin K, Pyridones, medicine.medical_treatment, MEDLINE, Hemorrhage, 030204 cardiovascular system & hematology, law.invention, 03 medical and health sciences, Percutaneous Coronary Intervention, 0302 clinical medicine, Pharmacotherapy, Double-Blind Method, Randomized controlled trial, law, Internal medicine, Atrial Fibrillation, Antithrombotic, medicine, Humans, 03.02. Klinikai orvostan, cardiovascular diseases, 030212 general & internal medicine, Acute Coronary Syndrome, Aged, Aged, 80 and over, Aspirin, business.industry, atrial fibrillation, anticoagulant therapy, acute coronary syndrome, apixaban, Anticoagulants, Percutaneous coronary intervention, Atrial fibrillation, General Medicine, Middle Aged, medicine.disease, Conventional PCI, Purinergic P2Y Receptor Antagonists, Cardiology, Pyrazoles, Drug Therapy, Combination, Female, business, Platelet Aggregation Inhibitors, Factor Xa Inhibitors

وصف الملف: text

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0eee6e081ac32c96877e78ea31fd314Test
https://doi.org/10.1056/nejmoa1817083Test

المؤلفون: Sidney Goldstein, Christopher O’Connor, Eric Yow, Huiman X. Barnhart, Sotir Marchev, Hani N. Sabbah, Gary Dunn, James E. Udelson, Melissa A. Daubert, Pamela S. Douglas

المصدر: Circulation: Heart Failure. 10

مصطلحات موضوعية: 0301 basic medicine, medicine.medical_specialty, Ejection fraction, business.industry, Placebo-controlled study, Stroke volume, 030204 cardiovascular system & hematology, Elamipretide, medicine.disease, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, Blood pressure, Tolerability, Heart failure, Internal medicine, Heart rate, Cardiology, Medicine, Cardiology and Cardiovascular Medicine, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::4dc18229311bea34e9646073aae85748Test
https://doi.org/10.1161/circheartfailure.117.004389Test

المؤلفون: Johanne SILVAIN, Sotir Marchev, Frans Van de Werf, Juhani Airaksinen, Ru San Tan, Daniel Duerschmied, Bela Merkely, Rolf Wachter, Bassem A. Samad, Philippe Gabriel STEG, Dirk Westermann, Didier CARRIE, Fernando Lanas, MICHELE SENNI, José Ramón Rumoroso, Wanwarang Wongcharoen, Grzegorz Opolski, Niall Mahon, Sandro Brusich

المساهمون: Clinical sciences, Cardiology

المصدر: Cannon, C P, Bhatt, D L, Oldgren, J, Lip, G Y H, Ellis, S G, Maeng, M, Merkely, B, Manassie, J, Januzzi, J L, Ten Berg, J M, Steg, P G, Hohnloser, S H & RE-DUAL PCI Steering Committee and Investigators 2017, ' Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation ', The New England Journal of Medicine, vol. 377, no. 16, pp. 1513-1524 . https://doi.org/10.1056/NEJMoa1708454Test

مصطلحات موضوعية: Male, Ticagrelor, Adenosine, Platelet Aggregation Inhibitors/therapeutic use, 030204 cardiovascular system & hematology, 0302 clinical medicine, Hemorrhage/chemically induced, Atrial Fibrillation, Medicine, Cardiac and Cardiovascular Systems, 030212 general & internal medicine, Stroke, risk, Kardiologi, Incidence, Research Support, Non-U.S. Gov't, General Medicine, Middle Aged, Clopidogrel, Dabigatran, Multicenter Study, Drug Therapy, Combination/adverse effects, Randomized Controlled Trial, Purinergic P2Y Receptor Antagonists/adverse effects, Cardiology, Platelet aggregation inhibitor, Drug Therapy, Combination, Female, Anticoagulants/adverse effects, Cardiology and Cardiovascular Medicine, medicine.drug, Risk, medicine.medical_specialty, Ticlopidine, Hemorrhage, Warfarin/adverse effects, Ticlopidine/analogs & derivatives, 03 medical and health sciences, Percutaneous Coronary Intervention, Internal medicine, Adenosine/adverse effects, Journal Article, Humans, cardiovascular diseases, Dabigatran/adverse effects, Aged, clopidogrel, Aspirin, business.industry, Atrial Fibrillation/drug therapy, percutaneous coronary intervention, Warfarin, Anticoagulants, ta3121, medicine.disease, Conventional PCI, Aspirin/therapeutic use, Purinergic P2Y Receptor Antagonists, incidence, business, Platelet Aggregation Inhibitors

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e13931000e1ba7b7512f50c0dfddb1d3Test
http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-145511Test

المؤلفون: Keith Fox, Konstantin Ramshev, Jacek Kubica, Miguel Urina, Gianfranco Parati, Sotir Marchev, Graeme Hankey, WILLIAM HEDDLE, Claudio Marabotti, Michel GALINIER, Vladimir Zadionchenko, Roman Libis, Fernando Lanas, Malcolm Robert Macleod, Tomas Janota, Markku Kaste, Vadim Mazurov, Larisa Yena, Aleksandr DEMIN

المصدر: Circulation. 130:138-146

مصطلحات موضوعية: Male, medicine.medical_specialty, Vitamin K, medicine.drug_mechanism_of_action, Morpholines, Embolism, Factor Xa Inhibitor, Administration, Oral, Hemorrhage, Thiophenes, Double-Blind Method, Rivaroxaban, aging, anticoagulant, stroke, Physiology (medical), Internal medicine, Atrial Fibrillation, medicine, Clinical endpoint, Humans, Stroke, Aged, Aged, 80 and over, Intention-to-treat analysis, business.industry, Warfarin, Anticoagulants, Atrial fibrillation, Middle Aged, medicine.disease, Treatment Outcome, Anesthesia, Cardiology, Female, Cardiology and Cardiovascular Medicine, business, Factor Xa Inhibitors, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::545541729d7d88f857ecdb78c105121cTest
https://doi.org/10.1161/circulationaha.113.005008Test

المؤلفون: Aleksandr Svistov, YAN CARLOS DUARTE VERA, Lars Kober, Konstantin Ramshev, David Preiss, Miguel Urina, Sotir Marchev, Peter Olexa, Søren Lund Kristensen, Albert HAGEGE, Pardeep Jhund, Mamas Mamas, Ali Vazir, Michel GALINIER, Vladimir Rafalskiy, John Mcmurray, Angus Nightingale, Fernando Lanas, MICHELE SENNI, Jose Silva-Cardoso, Michael Zile, José Albuquerque De Figueiredo Neto, Elena Shutemova, Raj Mohindra, Natalie Bello, Gian Battista Danzi

المساهمون: Neyses, Ludwig [collaborator]

المصدر: Kristensen, S L, Preiss, D, Jhund, P S, Squire, I, Cardoso, J S, Merkely, B, Martinez, F, Starling, R C, Desai, A S, Lefkowitz, M P, Rizkala, A R, Rouleau, J L, Shi, V C, Solomon, S D, Swedberg, K, Zile, M R, McMurray, J J V, Packer, M & PARADIGM-HF Investigators and Committees 2016, ' Risk Related to Pre-Diabetes Mellitus and Diabetes Mellitus in Heart Failure With Reduced Ejection Fraction : Insights From Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure Trial ', Circulation. Heart Failure, vol. 9, no. 1 . https://doi.org/10.1161/CIRCHEARTFAILURE.115.002560Test
Circulation. Heart Failure
Circulation. Heart failure, 9(1). United States (2016).

مصطلحات موضوعية: Blood Glucose, Male, Prediabetic State/blood, Time Factors, endocrine system diseases, Heart Failure/blood/diagnosis/drug therapy/mortality/physiopathology, Left, heart failure, Tetrazoles, Aminobutyrates/adverse effects, Angiotensin-Converting Enzyme Inhibitors, Comorbidity, Kaplan-Meier Estimate, 030204 cardiovascular system & hematology, Sacubitril, Ventricular Function, Left, Multidisciplinaire, généralités & autres [F99] [Sciences du vivant], 0302 clinical medicine, Enalapril, Risk Factors, Diabetes Mellitus/blood, Prevalence, Heart Failure/blood, Ventricular Function, Single-Blind Method, 030212 general & internal medicine, Prospective Studies, Enalapril/adverse effects/therapeutic use, Prediabetic State/blood/diagnosis/epidemiology/mortality, Ejection fraction, Aminobutyrates, Hazard ratio, clinical trial, Hemoglobin A, Angiotensin Receptor Antagonists/adverse effects, Middle Aged, Clinical trial, Drug Combinations, Treatment Outcome, Valsartan, Angiotensin-Converting Enzyme Inhibitors/adverse effects, diabetes mellitus, Cardiology, Female, Tetrazoles/adverse effects, Cardiology and Cardiovascular Medicine, medicine.drug, medicine.medical_specialty, prognosis, treatment outcome, Aged, Angiotensin Receptor Antagonists, Biomarkers, Diabetes Mellitus, Disease-Free Survival, Heart Failure, Hemoglobin A, Glycosylated, Humans, Prediabetic State, Proportional Hazards Models, Risk Assessment, Stroke Volume, Glycated Hemoglobin A/metabolism, Glycosylated, Multidisciplinary, general & others [F99] [Life sciences], Diabetes Mellitus/blood/diagnosis/epidemiology/mortality, Enalapril/adverse effects, Hemoglobin A, Glycosylated/metabolism, 03 medical and health sciences, Angiotensin-Converting Enzyme Inhibitors/adverse effects/therapeutic use, Diabetes mellitus, Internal medicine, medicine, Glycated Hemoglobin, Blood Glucose/metabolism, business.industry, Proportional hazards model, Biphenyl Compounds, Angiotensin Receptor Antagonists/adverse effects/therapeutic use, nutritional and metabolic diseases, Aminobutyrates/adverse effects/therapeutic use, Original Articles, medicine.disease, Surgery, Tetrazoles/adverse effects/therapeutic use, Heart failure, business, Biomarkers/blood

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4175b6b03be4e6fe28284823591aa9dbTest
http://hdl.handle.net/11573/885449Test

المؤلفون: Aleksandr Svistov, Oksana Drapkina, William Strain, YAN CARLOS DUARTE VERA, Lars Kober, Julio Núñez, Konstantin Ramshev, Manuel Martinez-Selles, Miguel Urina, Thomas Muenzel, Kamal Sharma, Sotir Marchev, MEHMET BIRHAN YILMAZ, Zbigniew Pijanowski, Peter Olexa, Albert HAGEGE, Pardeep Jhund, Mamas Mamas, Jan Krupicka, Marcelo Sanmartin-Fernandez, Michel GALINIER, Vladimir Rafalskiy, John Mcmurray, Roman Libis, Angus Nightingale, Fernando Lanas, MICHELE SENNI, Richard Bogle, Michael Zile, José Albuquerque De Figueiredo Neto, Biykem Bozkurt, Philippe Gosse, Evgeny Zhilyaev, Elena Shutemova, Fernando Manzur, Raj Mohindra, Natalie Bello, Gian Battista Danzi, DİLEK URAL, ROMAN FREIXA-PAMIAS

المساهمون: Neyses, Ludwig [collaborator]

المصدر: Dipòsit Digital de la UB
Universidad de Barcelona
The New England journal of medicine, 371(11), 993-1004. United States (2014).
McMurray, J J V, Packer, M, Desai, A S, Gong, J, Lefkowitz, M P, Rizkala, A R, Rouleau, J L, Shi, V C, Solomon, S D, Swedberg, K, Zile, M R & PARADIGM-HF Investigators and Committees 2014, ' Angiotensin-neprilysin inhibition versus enalapril in heart failure ', The New England Journal of Medicine, vol. 371, no. 11, pp. 993-1004 . https://doi.org/10.1056/NEJMoa1409077Test

مصطلحات موضوعية: Male, Hyperkalemia, Tetrazoles, Angiotensin-Converting Enzyme Inhibitors, Aminobutyrates/adverse effects, Kaplan-Meier Estimate, Insuficiència cardíaca, Sacubitril, Enalapril, Ús terapèutic, Enalapril/adverse effects/therapeutic use, Ejection fraction, Aminobutyrates, Hazard ratio, General Medicine, Angiotensin Receptor Antagonists/adverse effects, Middle Aged, Systèmes cardiovasculaire & respiratoire [D03] [Sciences de la santé humaine], Hospitalization, Drug Combinations, Valsartan, Angiotensin-Converting Enzyme Inhibitors/adverse effects, Cardiology, Neprilysin, Female, medicine.symptom, Tetrazoles/adverse effects, medicine.drug, Angiotensines, medicine.medical_specialty, Angiotensins, Heart failure, Enalapril/adverse effects, Angiotensin Receptor Antagonists, Angiotensin-Converting Enzyme Inhibitors/adverse effects/therapeutic use, Double-Blind Method, Internal medicine, medicine, Humans, Aged, Hospitalization/statistics & numerical data, Heart Failure, business.industry, Heart Failure/drug therapy/mortality, Biphenyl Compounds, Angiotensin Receptor Antagonists/adverse effects/therapeutic use, Therapeutic use, Stroke Volume, Aminobutyrates/adverse effects/therapeutic use, medicine.disease, Heart Failure/drug therapy, R1, Endocrinology, Tetrazoles/adverse effects/therapeutic use, Cardiovascular & respiratory systems [D03] [Human health sciences], business, Neprilysin/antagonists & inhibitors, RA, Sacubitril, Valsartan

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::057eafc951e64542d7bae65b6ab4fe32Test
http://hdl.handle.net/2445/178508Test

المؤلفون: Keith Fox, Konstantin Ramshev, Jacek Kubica, Miguel Urina, Sotir Marchev, Graeme Hankey, WILLIAM HEDDLE, Claudio Marabotti, Michel GALINIER, Philippe Gabriel STEG, Gerald Kneller, Vladimir Zadionchenko, Roman Libis, Fernando Lanas, Malcolm Robert Macleod, Tomas Janota, Geoffrey Donnan, Dorairaj Prabhakaran, Markku Kaste, Vadim Mazurov, Larisa Yena, Ka Sing Lawrence Wong, Tissa Wijeratne, Aleksandr DEMIN, Bo Norrving

المصدر: The Lancet. Neurology. 11(4)

مصطلحات موضوعية: medicine.medical_specialty, Morpholines, Medizin, Thiophenes, law.invention, Randomized controlled trial, Double-Blind Method, Rivaroxaban, law, Internal medicine, Atrial Fibrillation, medicine, Clinical endpoint, Secondary Prevention, Humans, Multicenter Studies as Topic, Stroke, Aged, Intention-to-treat analysis, business.industry, Hazard ratio, Warfarin, Anticoagulants, Atrial fibrillation, medicine.disease, Intention to Treat Analysis, Treatment Outcome, Ischemic Attack, Transient, Cardiology, Neurology (clinical), business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f941e71cd053bbf44e9f024af2869bfTest
https://pubmed.ncbi.nlm.nih.gov/22814536Test

المؤلفون: Keith Fox, Scott Berkowitz, Konstantin Ramshev, Jacek Kubica, Miguel Urina, Sotir Marchev, Graeme Hankey, WILLIAM HEDDLE, Claudio Marabotti, Michel GALINIER, Philippe Gabriel STEG, Vladimir Zadionchenko, Fernando Lanas, Juan Mauricio Pardo-Oviedo, Malcolm Robert Macleod, Dorairaj Prabhakaran, Vadim Mazurov, Larisa Yena, Aleksandr DEMIN

المساهمون: Mount Sinai Medical Center, Icahn School of Medicine at Mount Sinai [New York] (MSSM), Division of Cardiovascular Research (EDINBURGH - DCVR), University of Edinburgh, Diener, Hans Christoph (Beitragende*r)

المصدر: New England Journal of Medicine
New England Journal of Medicine, Massachusetts Medical Society, 2011, 365 (10), pp.883-91. ⟨10.1056/NEJMoa1009638⟩
The New England Journal of Medicine
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario
ResearcherID
BASE-Bielefeld Academic Search Engine

مصطلحات موضوعية: Male, [SDV]Life Sciences [q-bio], Embolism, Medizin, Management of atrial fibrillation, Administration, Oral, Randomization, 030204 cardiovascular system & hematology, MESH: Intention to Treat Analysis, chemistry.chemical_compound, 0302 clinical medicine, MESH: Aged, 80 and over, Rivaroxaban, Edoxaban, Atrial Fibrillation, Medicine, MESH: Double-Blind Method, 030212 general & internal medicine, MESH: Warfarin, Stroke, MESH: Treatment Outcome, Aged, 80 and over, MESH: Aged, MESH: Middle Aged, Hazard ratio, Diabetes, General Medicine, Middle Aged, MESH: Thiophenes, 3. Good health, Intention to Treat Analysis, MESH: Atrial Fibrillation, Treatment Outcome, Anesthesia, Hypertension, MESH: Administration, Oral, Female, MESH: Hemorrhage, medicine.drug, Morpholines, MESH: Morpholines, Hemorrhage, Thiophenes, MESH: Anticoagulants, MESH: Stroke, Dabigatran, 03 medical and health sciences, Double-Blind Method, Humans, Aged, HAS-BLED, MESH: Humans, business.industry, Warfarin, Anticoagulants, medicine.disease, MESH: Male, chemistry, business, MESH: Female, MESH: Embolism

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a251ed4738fc9d57f063feef4b22b7bfTest
https://hal.univ-brest.fr/hal-01038111Test

المؤلفون: Lars Kober, Paulo Bettencourt, Oleksii Korzh, Sotir Marchev, Elena Pavlyukova, Frieder Braunschweig, Olga Moiseeva, Oleg Narusov, Oleh Kraidashenko, Catalina Arsenescu Georgescu, Gerald Maurer, Michel GALINIER, Sergey Nedogoda, Ulf Näslund, Dario C Sobral Filho, Vyacheslav Yurievich Mareev, Piotr Ponikowski, Andriy Bazylevych, Niall Mahon, Vojtech Melenovsky, Jan Zbigniew Peruga, Laurence Howes

المصدر: Swedberg, K, Komajda, M, Böhm, M, Borer, J S, Ford, I, Dubost-Brama, A, Lerebours, G, Tavazzi, L, SHIFT Investigators & Gøtzsche, O 2010, ' Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study ', Lancet, vol. 376, no. 9744, pp. 875-85 . https://doi.org/10.1016/S0140-6736Test(10)61198-1

مصطلحات موضوعية: Male, Heart disease, Enfermedad cardiovascular, Placebo-controlled study, Kaplan-Meier Estimate, Severity of Illness Index, Cardiovascular Agents/Administration & Dosage, Benzazepines/*Therapeutic Use, Heart Failure/*Drug Therapy, Electrocardiography, Tratamiento médico, Heart Rate, Medicine, Ivabradine, Sinoatrial Node, Ejection fraction, Benzazepines/Adverse Effects, General Medicine, Orvostudományok, Middle Aged, Heart Failure/Complications, Treatment Outcome, Anesthesia, Cardiology, Heart Rate/*Drug Effects, Female, medicine.symptom, medicine.drug, Adult, Bradycardia, medicine.medical_specialty, Placebo, Klinikai orvostudományok, Cardiovascular Agents/*Therapeutic Use, Heart Failure/Physiopathology, Double-Blind Method, Internal medicine, Heart rate, Heart Failure/*Mortality, Humans, Kaplan-Meiers Estimate, Aged, Heart Failure, business.industry, Cardiovascular Agents, Benzazepines, medicine.disease, Benzazepines/Administration & Dosage, Heart failure, Chronic Disease, Sinoatrial Node/*Drug Effects, Cardiovascular Agents/Adverse Effects, business

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea2074c9e4b1a804f7c371a9dc2aeb4aTest